Search

Search Constraints

You searched for: Author/Creator Dierlamm, Judith

Search Results

2. Cytogenetics of extramedullary manifestations in multiple myeloma. (1st February 2013)

3. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Issue 10216 (21st December 2019)

4. Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cells. Issue 12 (2nd December 2017)

6. MALT1 sequencing analyses in marginal zone B-cell lymphomas reveal mutations in the translocated MALT1 allele in an IGH-MALT1-positive MALT lymphoma. Issue 10 (3rd October 2017)

8. Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients. (8th October 2017)

9. PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial. Issue 2 (February 2021)

10. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Issue 10114 (23rd December 2017)